Abstract
Oral contraceptive therapy should be added to the list of those predisposing factors known to enhance yeast growth in the vagina. Thirteen patients with yeast vulvovaginitis due to oral contraceptive therapy were seen during a six-month period. The potassium hydroxide (KOH) preparation confirmed the diagnosis in 11 of these patients; in selected patients, cultures were necessary. The germ-tube method of identification was rapid and efficient. Accepted methods for treatment of yeast vulvovaginitis may be only temporarily effective unless the oral contraceptive is discontinued.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
